Swedish vendor signed the health care IoT deal with AstraZeneca, China’s Wuxi national Hi-Tech District and China Mobile Group Jiangsu.
Ericsson signed a memorandum of understanding with China’s Wuxi national Hi-Tech District, China Mobile Group Jiangsu and AstraZeneca to partner on health care internet of things services.
The agreement calls for the four parties to work together to develop and promote an IoT-based disease management solutions, and display smart health care solutions in therapy areas such as respiratory, cardiovascular, metabolic, gastrointestinal diseases and oncology. AstraZeneca will also work with the Wuxi government to launch its China Commercial Innovation Center in the second half of 2017.
AstraZeneca is set to work with cross-sector partners in the first half of this year to establish the IoT Healthcare Alliance, which is expected to leverage government bodies, enterprises, universities, research institutions and hospitals to facilitate standardization of IoT for the health care industry and the commercialization of pilot projects to speed up local incubation.
Ericsson said it will provide technical support for AstraZeneca to connect health care equipment and integrate end-to-end resources by introducing narrowband-IoT technology. Ericsson is also set to work with China Mobile Jiangsu to trial new applications using cellular IoT technologies and provide network terminal management systems to support real-time surveillance and equipment management.
In parallel, Ericsson will also support the government on the construction of a health care IoT base and innovation center in Wuxi and Jiangsu using its Device Connection Platform.
“This partnership represents a breakthrough for Ericsson to enter the area of health care. We believe that with the support of government as well as with the help of China Mobile and AstraZeneca our IoT connection technology will be applied in health care scenarios to realize its full potential,” said Juntao Zhao, president of Ericsson China, in a statement. “As a result, Chinese patients can benefit from more advanced and precise disease management solutions. This will also allow us to contribute to the development of IoT health care covering Wuxi, Jiangsu and the entire country.”
